Patent US4769318A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4769318A Expired / Lapsed US ⏱️ 0.0 years remaining

Additive solution for blood preservation and activation

Assignee: Japanese Red Cross Society
•
Filing: 1987-04-15
•
Granted: 1988-09-06
•
Expires: 2007-04-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed an additive solution for blood preservation and activation, which comprises a phosphoenolpyruvic acid represented by the following formula (I): <IMAGE> (I) wherein R1 represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms, R2 and R3 represent a hydrogen atom, an alkali metal or an alkyl group having 1 to 12 carbon atoms respectively, a saccharide, adenine and an organic acid and/or a pharmaceutically acceptable alkali metal salt of the organic acid.

Inventors

  • 👤 Naotaka Hamasaki
  • 👤 Shigeru Sasakawa
  • 👤 Masayuki Shiba

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 04:58
CPC Classifications
A; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/126

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 98 words
An additive solution for blood preservation and activation, comprising 10 to 100 mmole/liter of a phosphoenolpyruvic acid represented by the following formula (I): ##STR3## wherein R 1 represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms, R 2 and R 3 each independently represent a hydrogen atom, an alkali metal or an alkyl group having 1 to 12 carbon atoms; 100 to 300 mmole/liter of a saccharide, 0.2 to 2 mmole/liter of adenine; and 3 to 50 mmole/liter of an organic acid and/or a pharmaceutically acceptable alkali metal salt of said organic acid.
Claim 2
Dependent Claim 98 words
An additive solution for blood preservation and activation, comprising 10 to 100 mmole/liter of a phosphoenolpyruvic acid represented by the following formula (I): ##STR3## wherein R 1 represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms, R 2 and R 3 each independently represent a hydrogen atom, an alkali metal or an alkyl group having 1 to 12 carbon atoms; 100 to 300 mmole/liter of a saccharide, 0.2 to 2 mmole/liter of adenine; and 3 to 50 mmole/liter of an organic acid and/or a pharmaceutically acceptable alkali metal salt of said organic acid.
Claim 3
Dependent Claim 21 words
The additive solution for blood preservation and activation according to claim 1, wherein said saccharide is sucrose, maltose, galactose or mannitol.
Claim 4
Dependent Claim 33 words
The additive solution for blood preservation and activation according to claim 1, wherein said organic acid is citric acid and said pharmaceutically acceptable alkali metal salt of the organic acid is sodium citrate.
Claim 5
Dependent Claim 50 words
The additive solution for blood preservation and activation according to claim 1, comprising an aqueous solution containing 10 to 100 mmole/liter of monosodium phosphoenolpyruvate, 100 to 300 mmole/liter of sucrose, maltose or mannitol, 0.2 to 2 mmole/liter of adenine and 3 to 50 mmole/liter of citric acid and/or trisodium citrate.
Claim 6
Dependent Claim 23 words
The additive solution for blood preservation and activation according to claim 4, wherein an amount of monosodium phosphoenolpyruvate is 50 to 100 mmole/liter.
Claim 7
Dependent Claim 32 words
A method for blood preservation and activation comprising mixing an effective amount of the additive solution according to claim 1 and blood and thereafter carrying out an incubation treatment immediately before transfusion.
Claim 8
Dependent Claim 18 words
The additive solution of claim 4 further comprising sodium chloride added to adjust osmolarity of the aqueous solution.
Claim 9
Dependent Claim 27 words
The method of claim 6 wherein the incubation treatment to be carried out immediately before transfusion comprises incubating the additive solution and blood mixture at 37° C.

References Cited (Backward Citations)

US4476221A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-06 1992-03-07 1992-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-06 1996-03-07 1996-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-06 2000-03-07 2000-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag